Clinical Trial Design Optimization and Problem Solving

BTC 6213 4 Quarter Hours
Course Level Graduate
Description Discusses quantitative data analysis in creating dynamic drug-disease models, strategic market models, trial simulation models, and integrated financial models, which enable key variable analysis in clinical trial developments in real time. This integrated approach allows all decisions in the design to optimize value against both scientific and business criteria simultaneously and continuously. Offers students an opportunity to learn to take a complete view of the development process at the outset -- across time, across the portfolio, and at all levels in the organization. This allows for greater insight into a drug's potential early in the process and leads to a more focused program for promising compounds, including an optimized clinical trial design. It also allows for earlier cessation of unpromising clinical trials, saving time and funds. Prereq. (a) BTC 6210 and (b) RGA 6100 or PJM 6000.

Course Sections

There are no current sections scheduled for this course.
Next Term Starts
  • Winter Term
    Jan 5, 2015 (12- and 6-week classes)
    Feb 17, 2015 (6-week classes)
  • Spring Term
    Apr 6, 2015 (12- and 6-week classes)
    May 18, 2015 (6-week classes)

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.

 

Call Toll Free:
877.668.7727
Email:
Contact Us
©